Search for: "Deas v. Deas" Results 81 - 100 of 830
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2022, 3:33 pm by Edward T. Kang
In 2020, Purdue pleaded guilty to felony violations for conspiracy to defraud the Unites States and to violate the anti-kickback statute (AKS), admitting to paying prescribers kickbacks to induce them to prescribe OxyContin and to misrepresenting to the DEA that Purdue maintained an effective anti-diversion program when, in actuality, Purdue marketed OxyContin to over 100 health care providers who the company knew were diverting opioids, and agreed to pay $5.5 in criminal fines and… [read post]
22 Jun 2022, 4:57 pm by Kurt R. Karst
Sovah must also “conduct a full physical inventory annually” of schedule II-V controlled substances on-hand consistent with DEA biennial inventory requirements that specifically includes drugs in the ADMs and vault. [read post]
16 Jun 2022, 10:05 am by James Kachmar
The Ninth Circuit recently tackled this issue in AK Futures LLC v. [read post]
13 Jun 2022, 3:45 pm by Bennett Cyphers
Its current and former clients in the US government include, at a minimum, the IRS, the DHS and its subsidiaries ICE and CBP, the DEA, and the FBI. [read post]
15 May 2022, 9:11 pm by The Regulatory Review Staff
The Regulatory Review would like to thank the members of the 2021-2022 editorial board for their passion and hard work in producing this publication. [read post]